top of page
AMD101 topical ophthalmic products to avoid injections for AMD
SCR101 topical skin products to treat redness
Facilitate and assist R&D activity
Assist corporate development for start-up companies
News
Jan 2023
Nov 2022
Oct 2022
Jun, 2022
Dec, 2021
Apr, 2021
Dec 2020
Jul, 2020
Dec, 2019
Feb, 2019
Jun, 2015
Presentation at Biotech Showcase in San Francisco (1/11/23, 10:30AM)
Japan patent for SCR101 topical skin products granted.
Head office in Palo Alto, California (San Francisco Bay Area)
A new PCT patent application for AMD101 topical ophthalmic products published
Re-domiciled California LLC registration to Delaware
Japan patent for AMD101 topical ophthalmic products issued.
Extensive pre-clinical activities to develop AMD101 topical ophthalmic products
US patent for SCR101 topical skin products issued.
Participated in an annual conference of Japanese Retina and Vitreous Society.
Presented AMD Therapeutics at RINK Festival in Kawasaki-City, Japan.
Registered AMD Therapeutics LLC in California
bottom of page